Herein, bioinformatics methods were used for constructing an innovative HDACs-related prognostic signature, which consists of five genes (BRD2, PBRM1, HDAC3, TAF1, and BRD3) was used to divide COAD patients with different outcomes. Here, HDAC3 is linked to colon adenocarcinoma.